139 related articles for article (PubMed ID: 31116037)
1. The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease.
Young CA; Ealing J; McDermott C; Williams T; Al-Chalabi A; Majeed T; Burke G; Pinto A; Dick D; Talbot K; Harrower T; Walsh J; Chandran S; Hanemann CO; Mills R; Tennant A
Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):317-327. PubMed ID: 31116037
[No Abstract] [Full Text] [Related]
2. Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature.
Edge R; Mills R; Tennant A; Diggle PJ; Young CA;
J Neurol; 2020 Mar; 267(3):607-615. PubMed ID: 31696295
[TBL] [Abstract][Full Text] [Related]
3. Caregiver burden and quality of life of patients with amyotrophic lateral sclerosis in India.
Thomas PT; Warrier MG; Sadasivan A; Balasubramanium B; Preethish-Kumar V; Nashi S; Polavarapu K; Krishna G; Vengalil S; Rajaram P; Nalini A
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):606-610. PubMed ID: 30039719
[TBL] [Abstract][Full Text] [Related]
4. Fatigue and anxiety mediate the effect of dyspnea on quality of life in amyotrophic lateral sclerosis.
Young C; Ealing J; McDermott C; Williams T; Al-Chalabi A; Majeed T; Roberts R; Mills R; Tennant A;
Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):390-398. PubMed ID: 34709092
[No Abstract] [Full Text] [Related]
5. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
[TBL] [Abstract][Full Text] [Related]
6. Use of coping strategies in MND/ALS: Association with demographic and disease-related characteristics.
Schlüter DK; Holland DP; Mills RJ; McDermott CJ; Williams TL; Young CA;
Acta Neurol Scand; 2019 Aug; 140(2):131-139. PubMed ID: 31058309
[TBL] [Abstract][Full Text] [Related]
7. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
Conde B; Winck JC; Azevedo LF
Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
[TBL] [Abstract][Full Text] [Related]
8. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
9. Health Status Perspectives in Amyotrophic Lateral Sclerosis.
Pinto S; de Carvalho M
Neurodegener Dis; 2017; 17(6):323-329. PubMed ID: 29084402
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.
Dalbello-Haas V; Florence JM; Krivickas LS
Cochrane Database Syst Rev; 2008 Apr; (2):CD005229. PubMed ID: 18425913
[TBL] [Abstract][Full Text] [Related]
11. Measuring life quality, physical function and psychological well-being in neurological illness.
O'Doherty LJ; Hickey A; Hardiman O
Amyotroph Lateral Scler; 2010 Oct; 11(5):461-8. PubMed ID: 20192883
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic features of ALS/MND in different phenotypes-data from a hospital-based registry.
Wei QQ; Chen Y; Chen X; Cao B; Ou R; Zhang L; Hou Y; Shang H
Brain Res Bull; 2018 Sep; 142():403-408. PubMed ID: 30232045
[TBL] [Abstract][Full Text] [Related]
13. Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trial.
Pagnini F; Marconi A; Tagliaferri A; Manzoni GM; Gatto R; Fabiani V; Gragnano G; Rossi G; Volpato E; Banfi P; Palmieri A; Graziano F; Castelnuovo G; Corbo M; Molinari E; Riva N; Sansone V; Lunetta C
Eur J Neurol; 2017 Apr; 24(4):578-586. PubMed ID: 28229508
[TBL] [Abstract][Full Text] [Related]
14. Observational study of patients in Spain with amyotrophic lateral sclerosis: correlations between clinical status, quality of life, and dignity.
Martínez-Campo Y; Homedes C; Lazaro A; Alarcón R; Campo D; Riera M; Domínguez R; Povedano M; Casasnovas C
BMC Palliat Care; 2017 Dec; 16(1):75. PubMed ID: 29258495
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for social withdrawal in amyotrophic lateral sclerosis/motor neurone disease.
Schlüter DK; Tennant A; Mills R; Diggle PJ; Young CA
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):591-598. PubMed ID: 30398087
[TBL] [Abstract][Full Text] [Related]
16. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis.
Sandstedt P; Johansson S; Ytterberg C; Ingre C; Holmqvist LW; Kierkegaard M
J Neurol Sci; 2016 Nov; 370():269-273. PubMed ID: 27772773
[TBL] [Abstract][Full Text] [Related]
17. Coping in people with amyotrophic lateral sclerosis and motor neuron disease: Systematic review.
Oh J; An J; Park K
J Clin Nurs; 2021 Jul; 30(13-14):1838-1853. PubMed ID: 33555628
[TBL] [Abstract][Full Text] [Related]
18. Trends of quality of life changes in amyotrophic lateral sclerosis patients.
Shamshiri H; Fatehi F; Abolfazli R; Harirchian MH; Sedighi B; Zamani B; Roudbari A; Razazian N; Khamseh F; Nafissi S
J Neurol Sci; 2016 Sep; 368():35-40. PubMed ID: 27538598
[TBL] [Abstract][Full Text] [Related]
19. Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.
Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Harrower T; Orrell RW; Annadale J; Hanemann CO; Scalfari A; Tennant A; Mills R;
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Mar; ():1-11. PubMed ID: 38465877
[No Abstract] [Full Text] [Related]
20. Patterns of symptom development in patients with motor neuron disease.
Walhout R; Verstraete E; van den Heuvel MP; Veldink JH; van den Berg LH
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):21-28. PubMed ID: 29037065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
